X Yan, P Liu, D Li, R Hu, M Tao, S Zhu, W Wu… - International …, 2022 - Elsevier
Objective Cancer immunotherapy based on immune checkpoint inhibitors (ICIs) has made
encouraging achievements in both clinical trials and real-world studies. The β-blockers, as …